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Functional Impairment of CD8 T Cells
by Regulatory T Cells
during Persistent Retroviral Infection
long-term chronic (persistent) infections. Once a virus
becomes persistent it is very difficult to eliminate. In
most cases an equilibrium is established between virus
proliferation and antiviral immunity such that the virus
persists with relatively little damage to the host. While a
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tion ensues. FV levels are low during the chronic or
persistent phase of infection, generally ranging between
one to ten infected cells per one hundred thousandSummary
nucleated spleen cells (Hasenkrug et al., 1998; Stromnes
et al., 2002). The predominant reservoir for persistentThe establishment of viral persistence generally re-
FV is B cells (Hasenkrug et al., 1998), although other cellquires evasion of the host CD8 T cell response. Here
types also harbor persistent virus to a much lesser extent.
we describe a form of evasion wherein the CD8 T cells
Chronic FV infection is associated with immunosuppres-
are fully capable of recognizing their cognate antigen sion, including suppression of CD8 T cell-mediated
but their effector functions are suppressed by regula- antitumor responses (Iwashiro et al., 2001a). This immu-
tory T cells. Virus-specific CD8 T cells adoptively nosuppression is transferable to naive mice by adoptive
transferred into mice persistently infected with Friend transfer of CD4 T cells, indicating that a subpopulation
virus proliferated and appeared activated, but failed of CD4 T cells, most likely adaptive regulatory T cells
to produce IFN or reduce virus loads. Cotransfer ex- (Bluestone and Abbas, 2003), mediates suppression of
periments revealed that a subpopulation of CD4 the antitumor response (Iwashiro et al., 2001a). Conversely,
T cells from persistently infected mice suppressed there is also a subpopulation of CD4 T cells, most likely
IFN production by the CD8 T cells. Treatment of Th1 type cells (Iwashiro et al., 2001b; Stromnes et al.,
persistently infected mice with anti-GITR antibody to 2002), that is required to keep persistent FV levels at a
ameliorate suppression by regulatory T cells signifi- stable, low level (Hasenkrug et al., 1998). Depletion of
cantly improved IFN production by transferred CD8 total CD4 T cells from persistently infected mice gener-
T cells and allowed a significant reduction in viral ally results in relapse of disease (Hasenkrug et al., 1998).
loads. The results indicate that CD4 regulatory T cells CD8 T cells are critical for recovery from the acute
contribute to viral persistence and demonstrate an phase of FV infection (Hasenkrug et al., 1995; Robertson
immunotherapy for treating chronic retroviral infec- et al., 1992), and even highly resistant mouse strains
tions. such as C57BL/6 fail to control acute infections in the
absence of a CD8 T cell response (Hasenkrug, 1999).
However, in the persistent phase of infection, depletionIntroduction
of CD8 T cells has no effect on virus levels (Hasenkrug
et al., 1998). One explanation of this transition is thatMany human viruses such as herpes viruses, hepatitis
some form of immunological escape has occurred. Vari-viruses, and retroviruses are able to evade immunologi-
ous mechanisms of escape from CD8 T cells have beencal destruction during acute infection and establish
described in which infected cells are not recognized by
CD8 T cells (Johnson and Desrosiers, 2002; Lucas et
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Table 1. Infectious Centers in Different Organs from Persistently Infected Mice
Spleen Lymph Node Bone Marrow Thymus Nucleated
Mouse Cells Cells Cells Cells Blood Cells Liver Cells
Mouse #1 21/106 47/106 6/106 nta 0/3  107 nt
Mouse #2 35/106 nt 2/106 0/3 107 0/3  107 0/3  107
Mouse #3 33/106 nt 3/106 0/3 107 0/3  107 0/3  107
Mouse #4 56/106 10/106 10/106 1/1 106 0/3  107 0/3  107
Mouse #5 46/106 5/106 6/106 0/3 107 0/3  107 0/3  107
The values are expressed as number of infectious centers (IC) per number of cells from the indicated tissue. The limit of detection for the
assay was one IC per 3  107 cells.
a nt, not tested.
ble and Lieberman, 1998) and HCV (Gruener et al., 2001; mately ten PCR cycles) during acute infection than the
respective signals during persistent infection (data notUrbani et al., 2002; Wedemeyer et al., 2002). However,
the reasons for CD8 dysfunction remain unclear. The shown), but the average env RNA to DNA ratios were
very similar during both phases of infection (27.0 and 27.6,current studies investigate the failure of CD8 T cell
responses to eradicate persistent infection in the Friend respectively). Therefore, viral transcription appeared to
be just as active during persistent infection as duringvirus model. Results indicated that recognition by CD8
T cells was intact, but effector function was impaired. acute infection.
Adoptive transfer experiments indicated that CD4
T cells from persistently infected mice could actively
Neither Mutation of the GagL CTL Epitope nor Clonal
suppress the effector function of CD8 T cells in vivo.
Deletion of GagL-Specific CD8 T Cells Account
Furthermore, ameliorating the suppressive activity of
for Virus Escape
regulatory T cells by in vivo treatment with anti-GITR
The finding of active virus transcription prompted us
antibody allowed adoptively transferred CD8 T cells to
to investigate mutation of a CD8 T cell epitope as a
produce IFN and eliminate a significant proportion of
mechanism of immunological escape. To date, one FV-
the persistent virus.
specific CD8 epitope has been described, an H-2Db-
restricted peptide from the leader portion of the F-MuLV
glycosylated gag protein (GagL) (Chen et al., 1996).Results
H-2Db/GagL tetramers (Schepers et al., 2002) were used
to determine whether GagL was a significant CD8 T cellPersistent FV Infections Are Not Latent
We first sought to determine whether the mechanism epitope by staining CD8 T cells from mice at 3 weeks
postinfection, the peak of the CTL response (Robertsonby which persistent FV escaped killing by CD8 T cells
was related to a loss of active provirus transcription in et al., 1992). Representative flow cytometry results com-
paring CD8 T cells from naive and acutely infectedchronically infected cells (latency). Previously we showed
that we could culture live virus from persistently infected mice are shown in Figures 1A and 1B, respectively. An
average of 2.7% of the CD8 T cells from the infectedmice (Hasenkrug et al., 1998), but it was possible that
in vitro culture may have activated transcription that mice stained tetramer-positive, indicating that GagL
was a significant CD8 epitope during acute FV infection.was silent in vivo. We therefore used amplification of
RNA by PCR as a sensitive method to detect transcrip- To determine whether the GagL CD8 T cell epitope
was mutated in persistently infected mice, PCR primerstion from cells taken directly ex vivo. Tissues from six
persistently infected mice were tested for the presence flanking the coding sequence were used to amplify pro-
viral DNA, which was then directly sequenced. Resultsof viral env RNA. Positive signals were obtained from
all spleens, lymph nodes, bone marrows, and thymuses. from 12 persistently infected mice all showed wild-type
sequences with no mutation of the CD8 T cell epitopeFive of the six mice had positive signals from nucleated
blood cells, and four of six liver samples were positive or sequences within 50 base pairs of both the 3 and
5 ends of the epitope sequence (data not shown). In(data not shown). In addition, infectious virus was de-
tected in cell suspensions from spleens, lymph nodes, addition, viral cDNAs from five of the same mice were
sequenced to investigate whether only transcriptionallyand bone marrows (Table 1). These results indicated
a wider tissue distribution of persistent FV than was active viruses had mutated the epitope. Again, only wild-
type sequences were found, indicating that mutationspreviously known and also that persistent FV was not
completely latent. However, they did not reveal whether in the GagL CD8 T cell epitope did not account for FV
persistence (data not shown).transcription was at a low level or a high level compared
to an acute infection. Since the spleen is one of the We tested for deletion of the T cells (Moskophidis et
al., 1993; Rich and Green, 2000) specific for the GagLmost active sites of virus replication during acute FV
infection, we chose this tissue to compare transcription epitope by staining spleen cells from persistently in-
fected mice with H-2Db/GagL tetramers. Results fromlevels during acute versus persistent infection using
real-time PCR. The ratios between viral RNA and DNA three representative mice are shown in Figure 1C. In
seven persistently infected mice tested, the percentagewere determined using host GAPDH signals as internal
controls. On average, both the viral RNA and DNA sig- of tetramer-positive CD8 cells averaged 1.6%, indicating
that the H-2Db/GagL-specific cell subset had not beennals were about one thousand times higher (approxi-
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and naive control mice, and at 3 days posttransfer,
spleen cells from the host mice were analyzed by flow
cytometry. In uninfected control recipients we found an
average of 2.4% of the splenic CD8 T cells to be CFSE-
labeled donor cells. The donor cells were low in expres-
sion of the CD43 activation marker and had retained full
CFSE signal, indicating that no proliferation had oc-
curred (Figure 2A). In contrast, when virus-specific CD8
T cells were adoptively transferred into persistently in-
fected mice, virtually all of the cells upregulated the
CD43 activation marker, and the bulk of the donor cells
underwent six cell divisions within 3 days (Figure 2B).
Proliferating CD8 T cells also expressed CD44 (data
not shown). By 7 days posttransfer almost all the CFSE
label was gone, indicating that more than seven cell
divisions had occurred (Figure 2C). At 1 week posttrans-
fer the CD8 donor cells had proliferated to an average
of 2.0  107 donor cells per spleen in the persistently
infected mice. These results indicated that the virus-
specific CD8 T cells had recognized and responded to
their cognate viral antigen.
FV-Specific CD8 T Cells Reduce Acute Infections
but Not Persistent Infections
Given the rapid proliferation and activation of the adop-Figure 1. Tetramer Staining of CD8 T cells in Naive, Acutely In-
tively transferred CD8 T cells, it was of interest to deter-fected, and Persistently Infected Mice
mine whether the transferred cells had any effect onAll cells are CD8 gated and stained with DbGagL tetramers.
levels of persistent virus. At 1 week posttransfer there(A) CD8 T cells from three naive mice.
(B) CD8 T cells from three acutely infected mice (21 days post- was no reduction in spleen infectious center levels; in
infection [dpi]). The geometric mean side scatter signal was fact, there was a slight increase (Figures 3A and 3B).
190.7  3.6. This increase could be accounted for by the infection
(C) CD8 T cells from persistently infected mice at 16 or 26 weeks
of the CD8 donor cells, which had an average of 1.5%postinfection (wpi) as indicated.
infection at 1 week posttransfer (as determined by de-The geometric mean side scatter signal was 174.7  2.3. The differ-
tection of viral antigen using flow cytometry, data notence in side scatter was statistically significant by Student’s t test,
p  .0001. shown). By 2 weeks posttransfer, infectious center lev-
els were still not reduced (Figure 3C). To confirm that
the TCR transgenic CD8 T cells had the capacity to
deleted. Interestingly, most of the tetramer-postive cells reduce viral loads in vivo, an adoptive transfer experi-
from the persistently infected mice had a significantly ment was performed into mice during acute infection.
lower side scatter profile compared to tetramer-postive By 1 week posttransfer the average infectious center
cells from the acutely infected mice (Figures 1B and 1C). levels were reduced from 107.0 per spleen to 105.3 per
Side scatter is a measure of granularity and a reflection spleen, a reduction of approximately 50-fold or almost
of the level of cytotoxic granules in CD8 T cells, indicat- ten million infectious centers per spleen (Figures 3D and
ing that the tetramer-postive CD8 T cells from the per- 3E). Thus, the TCR Tg CD8 T cells were effective at
sistently infected mice had lower levels of cytotoxic reducing acute Friend virus infection but ineffective at
granules than the cells in the acutely infected mice. reducing persistent infection, despite their activated ap-
pearance and ability to proliferate.
To determine whether higher levels of TCR Tg CD8Persistent Friend Virus Does Not “Hide”
from CD8 T Cells T cell engraftment could account for the higher reduc-
tion of infection in the acutely infected mice, real num-To determine whether persistent Friend virus was utiliz-
ing escape mechanisms (Oldstone, 1997) such as down- bers of cells were determined by repeating the adoptive
transfers using green fluorescent CD8 T cells obtainedregulation of MHC class I molecules, interference with
antigen processing, sequestration of antigen, or other con- from a cross between TCR transgenic mice and green
fluorescent protein (GFP) transgenic mice. Interestingly,cealment mechanisms, we tested whether virus-specific
CD8 T cells would become activated upon adoptive there was an average of 5-fold fewer donor CD8 T cells
in the acutely infected mice than in the persistently in-transfer into persistently infected mice. CD8 T cells
from B6 mice carrying a transgenic T cell receptor (TCR) fected mice at 1 week posttransfer (Table 2A). Lower
engraftment levels in the acutely infected mice werespecific for the H-2Db-restricted GagL epitope (Ohlen et
al., 2002) were adoptively transferred into persistently likely due to less antigenic stimulation during the first
few days after transfer when virus levels were still low.infected mice. The TCR Tg CD8 T cells were labeled
with CFSE prior to adoptive transfer so that in vivo prolif- Thus, although the persistently infected mice became
better engrafted with virus-specific donor cells than theeration could be measured. Four million CD8 T cells
were injected intravenously into persistently infected acutely infected mice, the cells were still not effective
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Figure 2. Proliferation and Activation of Vi-
rus-Specific TCR Tg CD8 T Cells after Trans-
fer into Persistently Infected Mice
Flow cytometry was used to detect upregula-
tion of the CD43 activation marker and loss
of CFSE staining on CD8-gated cells taken
from spleens of recipient mice at the indi-
cated time points.
(A) CD8-gated T cells 3 days after adoptive
transfer into naive mice.
(B) CD8-gated T cells 3 days after adoptive
transfer into persistently infected mice.
(C) CD8-gated T cells 7 days after adoptive
transfer into persistently infected mice.
The numbers at the top indicate the number
of cell divisions of the CFSE-labeled cells di-
rectly below each box. The number of cell
divisions was calculated empirically.
in reducing virus levels. These results suggested the preparation of cells inoculated into acutely infected
mice.possibility that the effector functions of the CD8 cells
were being suppressed in the persistently infected mice.
Suppression of CD8 T Cells Producing IFN by CD4
T Cells from Persistently Infected MiceVirus-Specific CD8 T Cells Fail to Produce IFN after
Transfer into Persistently Infected Mice Previously we found that mice persistently infected with
Friend virus had increased levels of CD4 regulatoryAs one measure of CD8 T cell effector function that
correlates with recovery from FV infection, intracellular T cells, which impaired their CD8 T cell-mediated rejec-
tion of tumors (Iwashiro et al., 2001a). To determinecytokine staining for interferon  (IFN) was determined
in TCR transgenic CD8 T cells adoptively transferred whether CD4 regulatory T cells were inhibiting the anti-
viral functions of virus-specific CD8 T cells, we per-into acutely infected or persistently infected mice. At 1
week posttransfer an average of 15.0% of the donor formed a cotransfer experiment in which acutely in-
fected mice received an infusion of GFP-labeled, TCRcells in acutely infected mice produced IFN whereas
only 2.4% of the CD8 T cells recovered from persis- Tg CD8 T cells and also received CD4 T cells from
either naive mice or persistently infected mice. Thetently infected mice produced IFN (p  .0286). Repre-
sentative flow cytometry plots are shown in Figure 4. CD4 T cells were genetically labeled (CD45.1), which
allowed us to analyze both the host and donor CD4Thus, although the virus-specific CD8 T cells prolifer-
ated and upregulated the CD43 activation marker follow- and CD8T cell subpopulations. At 1 week postinfection
host and donor T cells from the spleens of recipient miceing adoptive transfer into persistently infected mice, the
cells were functionally impaired relative to the same were analyzed for cytokine expression by intracellular
Figure 3. Infectious Center Levels after Adop-
tive Transfer of Virus-Specific TCR Tg CD8
T Cells
The data from experiments (A)–(C) were ob-
tained from (B10 x A.BY)F1 mice that were
infected with FV at least 8 weeks prior to
adoptive transfer (persistently infected mice).
The data from experiments (D) and (E) are
pooled from two experiments, one with (B10 x
A.BY)F1 mice and one with (B6.SJL x A.BY)F1
mice. The mice were infected with FV 1 day
prior to adoptive transfer. (B6.SJL x A.BY)F1
mice were used so that the Ly5 (CD45.1)
marker could be used to distinguish host and
donor cells to obtain the data in Table 2B. No
strain-associated differences were seen in
these experiments. The difference in means
(log10) between (D) and (E) is statistically sig-
nificant by the Mann-Whitney test, p 
0.0001.
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Table 2. Effects of Infection Status and Anti-GITR Treatment on Adoptively Transferred TCR Tg CD8 T Cells
A. Reconstitution Levels of TCR Tg CD8 T Cells in Acutely Infected and Persistently Infected Micea
1 Week Posttransfer into 1 Week Posttransfer into
Acutely Infected Mice Persistently Infected Mice
Percentage of total spleen cells that were of donor origin (mean) 1.4% 4.5%
Percentage of CD8 T cells that were of donor origin (mean) 8.6% 28.0%
Number of donor CD8 T cells per spleen (mean) 3.9  106 2.0  107
B. Effects of Anti-GITR on Cytokine Production in Persistently Infected Miceb
% Donor CD8 T Cells % Donor CD8 T Cells
Treatment Producing IFN Producing TNF
Adoptive transfer of 8  106 TCR Tg CD8 T cells plus rat Ig 19.3% 7.0%
Adoptive transfer of 8  106 TCR Tg CD8 T cells plus anti-GITR 35.0% 20.4%
P value .0014 .0006
a For acute infections the CD8 T cells were transferred 1 day after infection, and the data were collected 1 week later (n  6 mice). For
persistent infections the mice were infected 2 months before adoptive transfer of CD8 T cells, and the data were collected 1 week later (n 
5 mice). To distinguish host from donor cells, the TCR transgenic mice were mated with green fluorescent protein transgenic mice to obtain
donor cells with green fluorescence.
b B6.PL (Thy 1.1 congenic) mice persistently infected with FV for 2 months were adoptively transferred with 8  106 CD8 T cells from B6
TCR Tg mice. The anti-GITR group received 70 	g of rat monoclonal anti-GITR every other day for a total of six injections beginning on the
day of adoptive transfer. The control group was treated with nonspecific rat immunoglobulin with the same dose and schedule. Statistical
analyses were done using the Mann-Whitney test (n  8 mice per group).
cytokine staining. There were significantly more IL-10-
producing CD4 T cells from persistently infected do-
nors than from naive donors (Figure 5B). Furthermore,
transfer of CD4 T cells from persistently infected mice
was associated with an increase in the percentage of
host CD4 T cells producing IL-10 (Figure 5B). Interest-
ingly, the cotransfer of CD4 T cells from persistently
infected mice significantly diminished the percentage
of IFN-producing CD8 T cells of both host and donor
origin (Figure 5A). There was no significant difference
in the level of host or donor CD4 T cells producing
IFN (Figure 5C), and there were no detectable IL-4
producing CD4 T cells in the host or donor T cells of
either of the groups (data not shown). Thus, CD4 T cells
from persistently infected mice produced immunosup-
pressive IL-10 and diminished CD8 T cell IFN re-
sponses in vivo.
Since CD4 T cells constitutively expressing CD25
are important regulatory T cells in the prevention of
autoimmune disease, the cotransfer experiment was re-
peated with CD4 T cells enriched for CD25-positive
or -negative subpopulations. Both the CD25-postitive
and -negative subpopulations of CD4 T cells sup-
pressed IFN production by cotransferred TCR Tg CD8
T cells (Figure 5D). Thus, the immunosuppressive CD4
T cells in this model are not confined to the subset ofFigure 4. Intracellular Cytokine Staining for CD8 T Cells Produc-
ing IFN CD4 T cells expressing high levels of CD25.
At 1 week posttransfer of 4  106 Friend virus (DbGagL)-specific
TCR transgenic CD8 T cells, spleens were harvested, and donor Treatment of Mice with Anti-GITR Antibody Allows
CD8 T cells were stained by intracellular cytokine staining for IFN. CD8 T Cells to Produce IFN and Reduce
Spleen cells were from either uninfected mice (A), acutely infected
Persistent Infectionmice at 1 week postinfection (B), or persistently infected mice (C).
We next sought to determine whether we could improveThe cells were stimulated with 1 micromolar DbGagL peptide during
the 5 hr incubation with monensin. The difference in the percentage the function of CD8 T cells by modulating the sup-
of IFN-producing CD8T cells between the two groups was statisti- pressive effects of regulatory T cells in persistently in-
cally significant by the Mann-Whitney test, p  .0286. Very similar fected mice. Persistently infected B6 congenic mice
results were obtained in a second experiment with 12 acutely in- were treated with a monoclonal antibody against the
fected and 8 persistently infected mice. The virus-specific CD8
GITR molecule, a treatment which has been shown todonor T cells had significantly higher side scatter in acutely infected
diminish the suppressive function of regulatory T cellsmice (mean  220) than in the persistently infected mice (mean 
186, p  .0001 by t test). in vivo (Shimizu et al., 2002). Anti-GITR monoclonal anti-
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Figure 5. Intracellular Cytokine Staining after Cotransfers of T Cells into Acutely Infected Mice
Percentages of T cells producing the indicated cytokines at 1 week post-adoptive transfer are indicated by the bars. The host mice were
acutely infected (A.BY x B10)F1. The donor TCR Tg CD8 T cells were from (B6.GFP x B6.TCR Tg)F1 mice and were gated by GFP expression.
Donor CD4 T cells were from naive or persistently infected (A.BY x B6.SJL) and were gated by CD45 expression. The cotransfers were done
with 2  107 CD4 T cells plus 4  106 CD8 TCR Tg T cells. P values for (A)–(C) were determined by Mann-Whitney tests, and the p value
for donor CD8 T cells in (A) was corrected for multiple comparisons using the Bonferroni posttest. (D) CD25-posititive and -negative
subpopulations of CD4 T cells from persistently infected mice were cotransferred with TCR Tg CD8 T cells and compared with cotransfers
of unfractionated CD4 T cells from naive mice (A) and two mice that received only TCR Tg CD8 T cells (*). P values were determined by
one-way analysis of variance using the Dunnett multiple comparisons posttest as well as the Bonferroni correction to be extremely conservative.
body treatment is nondepleting in vivo and acts by deliv- improvement in the ability of CD8 T cells to decrease
in spleen virus loads (data not shown).ering an agonistic signal to cell surface GITR, which
is constitutively expressed by CD4 regulatory T cells To determine the effects of anti-GITR therapy on cyto-
kine production by donor TCR Tg CD8 T cells, the(Shimizu et al., 2002). By itself, anti-GITR treatments had
no effect on levels of persistent infection (Figure 6C). combination therapy was repeated, and spleen cells
were analyzed for IFN and TNFproduction by intracel-However, when anti-GITR therapy was combined with
adoptive transfer of 4  106 TCR Tg CD8 T cells, there lular cytokine staining. At 2 weeks post-adoptive trans-
fer the anti-GITR group had almost twice as many donorwas a significant reduction in virus loads (Figure 6D).
Interestingly, when the number of adoptively transferred cells producing IFN and triple the number producing
TNF (Table 2B). Thus, the effect of anti-GITR therapyTCR Tg CD8 T cells was increased to 8  106 cells per
mouse, a significant decrease in spleen virus levels was correlated with improved production of antiviral cyto-
kines by the adoptively transferred CD8 T cells.also observed (Figure 6F). Thus, the effects of regulatory
T cells could be partially overcome by adding sufficient
numbers of CD8 T cells. An even greater decrease was Discussion
observed when anti-GITR therapy was combined with
adoptive transfer of 8  106 TCR Tg CD8 T cells per To our knowledge this is the first description of a virus
utilizing the regulatory T cell system to escape CD8mouse (Figure 6H). Compared with control mice (Figure
6E), combined anti-GITR and adoptive transfer therapy T cell responses. It will be of interest to determine
whether this escape is an inadvertent consequence ofproduced a striking reduction from an average of 28,000
infectious centers per spleen to an average of only 500 the infection or dependent on specific viral genes that
actively induce regulatory T cells. The generation ofper spleen (Figure 6H). In agreement with the results
from the cotransfer studies which showed immunosup- adaptive regulatory T cells may be a normal process
that occurs to prevent immunopathological damage aspressive activity in both CD25-positive and -negative
subsets of CD4 T cells, depletion of CD25 T cells from antigen levels decrease over the course of an infection
(MacDonald et al., 2002; Sakaguchi, 2003). Such activitypersistently infected mice did not produce a consistent
CD8 T Cell Dysfunction
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McGuirk and Mills, 2002; Uraushihara et al., 2003), and
it appears that function rather than cell surface markers
distinguish regulatory T cells from helper T cells. One
function we associated with immunosuppression was
production of IL-10. However, although IL-10 production
correlated with immunosuppression we do not believe
it is the sole effector in vivo. In preliminary experiments,
blockade of the IL-10 receptor was not sufficient to
restore function in CD8 T cells transferred into persis-
tently infected mice (data not shown). Thus, IL-10 may
be either a surrogate marker for immunosuppressive
T cells or just one of multiple factors required for the
observed effects.
The CD8 T cell dysfunction in persistent FV infection
is different from the progressive loss of effector func-
tions due to chronic stimulation that occurs in persistent
lymphocytic choriomeningitis virus (LCMV). In LCMV in-
fections, the CD8 T cells become “exhausted” due to
continuous stimulation, fail to develop into memory
cells, and lose their effector function over several weeks
of time (Onami et al., 2002). However, in the current FV
experiments, transferred naive CD8 T cells showed
dysfunction already by 1 week posttransfer, a time point
Figure 6. Reduction in Spleen Virus Loads after Anti-GITR Therapy
when antigen stimulation should be eliciting maximumCombined with Adoptive Transfer of Virus-Specific TCR Tg CD8
responsiveness rather than exhaustion. Our experi-T Cells
ments do not exclude a contributory role for exhaustionEach dot represents spleen virus loads from a single mouse. In
in CD8 T cell dysfunction during persistent FV infec-(A)–(D), B6.SJL (CD45.1 congenic) mice were treated as indicated.
The difference between the geometric means (log10) of groups (B) tions. In fact, the reason that anti-GITR therapy in the
and (D) is statistically significant (p  .0027). B6.PL (Thy 1.1 con- absense of CD8 T cell transfer was ineffective in reduc-
genic) mice were used in experiments (E)–(H). The difference be- ing virus loads could be attributable to functional ex-
tween the geometric means (log10) of groups (F) and (H) is statistically haustion of the endogenous population of virus-specificsignificant (p  .0482). Statistical analyses were done by unpaired
CD8 T cells. Alternatively, the functional impairment oft tests. A repeat of this experiment gave similar results with an
CD8 T cells by regulatory T cells could be long-livedaverage decrease to less than 500 infectious centers per spleen
following combined treatment (data not shown). or even irreversible. The adoptive transfers of CD8
T cells into persistently infected mice provided us with
sufficient numbers of cells to study the effects of this very
by regulatory cells could lead to incomplete clearance
interesting in vivo environment. Although other factors
of pathogens and contribute to persistent infections
may contribute to the immunosuppressive environment
(Belkaid et al., 2001, 2002; MacDonald et al., 2002;
in persistently infected mice, the current experiments
McGuirk et al., 2002). Alternatively, epitopes encoded demonstrate that the presence of immunosuppressive
by viral genes may be specifically inducing regulatory CD4 T cells is sufficient to account for dysfunction of
T cells. For example, a viral epitope might trigger regula- virus-specific CD8 T cells.
tory T cells that normally function to maintain tolerance It is worth noting that it was recently shown that GITR
to an endogenous retroviral protein. Endogenous ret- ligand (Kim et al., 2003) could act as a costimulatory
roviral elements make up a significant proportion of the molecule for effector T cells (Tone et al., 2003). It is
mouse genome and a minimum of 8% of the human unclear whether anti-GITR antibody works in the same
genome (Hughes and Coffin, 2001; International Human manner, but the possibility exists. Thus, costimulation
Genome Sequencing Consortium, 2001; Venter et al., of the CD8 T cells could contribute to the therapeutic
2001). effects of the anti-GITR antibody treatments. However,
The immunosuppressive CD4 T cells demonstrated it is very unlikely that costimulation of the CD8 T cells
in this study may be the same cells we previously found could account for all of the increased CD8 T cell func-
to be associated with depressed antitumor responses tion in our experiments. First of all, preactivation of the
in mice persistently infected with FV (Iwashiro et al., CD8 T cells with anti-CD3 antibody combined with
2001a). As yet we have not identified a single or set of costimulation by anti-CD28 antibody prior to adoptive
cell surface markers that conclusively distinguishes the transfer did not improve their activity (data not shown).
immunsuppressive subpopulation of CD4 T cells in Second, lack of costimulation cannot explain why adop-
vivo. Treatments with anti-GITR, which had a clear bio- tive transfer of twice as many CD8 T cells overcame
logical effect, were not associated with detectable suppression. Finally, the cotransfer experiments directly
changes in CD25 or other activation markers such as demonstrate that activity by regulatory CD4 T cells can
CD69 and CD38 (data not shown). Our results indicate inhibit CD8 T cell function. Thus, it appears that the
that immunosuppressive CD4 T cells are not solely in anti-GITR effect is predominantly on the regulatory
the CD25-positive subset (Figure 5D). CD25 negative T cells but that costimulation of the CD8 T cells may
CD4 T cells with suppressive function have recently contribute to the observed effects.
It was unexpected that suppression of the CD8 re-been described in other studies (Bynoe et al., 2003;
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on a C57BL/6 or B6.GFP background as indicated, and greater thansponse by regulatory T cells occurred at the level of
90% of the CD8 T cells contained a TCR specific for the DbGagLeffector function rather than proliferation and activation.
FV epitope (Chen et al., 1996; Ohlen et al., 2002). All mice wereGiven the massive proliferation of the adoptively trans-
females of 12–24 weeks of age at the beginning of the experiments
ferred cells, it is quite remarkable that no effect on the and were treated in accordance with the regulations and guidelines
virus load was produced. In experiments where this of the Animal Care and Use Committee of the Rocky Mountain
Laboratories and the National Institutes of Health.same TCR transgene was expressed in mice coexpress-
ing the GagL epitope as a transgene, tolerance occurred
Virus and Virus Infectionmainly at the level of proliferation (Ohlen et al., 2002).
The FV stock used in these experiment was an FV complex con-However, there was likely functional impairment of the
taining B-tropic Friend murine leukemia helper virus (F-MuLV) andCD8 T cells from the double transgenic mice as well,
polycythemia-inducing spleen focus-forming virus (Lilly and
since GagL-specific CD8 T cells in the periphery were Steeves, 1973). The stock was prepared as a 10% spleen cell ho-
not cytotoxic when taken directly ex vivo and did not mogenate from BALB/c mice infected 14 days previously with 3000
spleen focus-forming units of uncloned virus stock. For virus chal-cause pathological damage in the mice (Ohlen et al.,
lenge experiments, mice were injected intravenously with 0.5 ml of2002). Peripheral tolerance may occur at different levels
phosphate-buffered balanced salt solution containing 1500 spleenon the same CD8 T cells depending on whether they
focus-forming units of Friend virus complex. Persistently infectedencounter antigen in the context of an inflammatory
mice were mice that had been infected at least 8 weeks prior to
infection or the context of a “self”-antigen during devel- experimentation. Virus levels are generally stable at approximately
opment. It is quite interesting and revealing that it is 104 infectious centers per spleen by 6–8 weeks postinfection.
possible to shut down effector function even in cells that
appear highly activated based on cell surface markers. Intracellular Cytokine Staining and Flow Cytometry
Cell surface and intracellular cytokine staining was performed usingClearly, the signals that lead to proliferation and upregu-
Becton Dickinson/Pharmingen reagents (except where noted) andlation of CD43 are not necessarily coupled to IFN pro-
the Cytofix/Cytoperm intracellular cytokine staining kit. T cell anti-duction or the ability to eliminate virus-infected cells.
bodies were: FITC-anti-CD43 (1B11), PE-anti-CD25 (PC61), PE-anti-
There are indications in the literature that induction CD44 (IM7), APC- anti-CD4(RM4-5), and APC-anti-CD8(53-6.7).
of regulatory T cells may be more than an idiosyncratic Dead cells (propidium idiodidehigh) were excluded from all cell surface
analyses. During the 5 hr incubation with monensin (2 	g/ml), cellsmechanism peculiar to Friend virus. MacDonald et al.
were incubated either with 1 micromolar DbGagL peptide (Chen ethave reported a strong association between the estab-
al., 1996) to specifically stimulate TCR Tg CD8 T cells or withlishment of chronic hepatitis C infections in humans and
plate-bound anti-CD3 and anti-CD28 (1 	g/ml) to obtain a broadthe expansion of CD4 regulatory T cells (MacDonald
perspective of the full range of T cell activity. Cells were washed
et al., 2002). It has also been shown that virus-specific twice, incubated with anti- Fc 2/3 receptor (2.4G2) to block Fc
CD8 T cells in chronic HCV infections are functionally receptors, and stained with APC-labeled anti-CD4 or anti-CD8 and
FITC-labeled anti-CD43 in round-bottom 96-well plates. The cellsimpaired (Gruener et al., 2001). Thus, it is possible that
were then washed, fixed, permeabilized, and incubated with PE-CD4 regulatory T cells may be causally involved in
conjugated monoclonal antibodies specific for IL-2 (CalTag, Burl-the functional impairment of CD8 T cells specific for
ingame, CA), IL-4, IL-10, IFN, or TNF. (Becton Dickinson). Datahepatitis C virus. HIV infections are also associated with
were acquired on a FACSCalibur flow cytometer (Becton Dickinson)
dysfunctional CD8 T cells (Lieberman et al., 2001; Mi- from CD4- or CD8-gated events. Analyses were done using BD
gueles et al., 2002; Trimble and Lieberman, 1998; Vinger- Cellquest Pro software (Version 4.0.1, Becton Dickinson).
hoets et al., 1998), and it has been shown that HIV pa-
tients with disease progession or active virus replication Virus-Specific DNA- and RNA-PCR
One microgram template DNA was prepared from single-cell sus-have increased frequencies of CD4 T cells producing
pensions of different mouse organs as indicated. F-MuLV env-spe-IL-10 (Ostrowski et al., 2001). Recently, it was also
cific proviral DNA was amplified using the upstream primer 5-AAGTshown that immune responses in HIV infections are con-
CTCCCCCCGCCTCTA-3 and the downstream primer 5-TGCCAG
trolled by CD4 regulatory T cells (Aandahl et al., 2004). CCATAGTTAGCC-3. The PCR cycle profile was: 45 s 95
C, 45 s
Thus, a link between CD4 regulatory T cells and CD8 55
C, and 45 s 72
C. Total RNA for PCR was extracted with Trizol
(Invitrogen) from 106 cells of the different organs from the sameT cell dysfunction is feasible in chronic HIV infections
persistently infected mice that were used for DNA preparation.as well. A high viral setpoint during the asymptomatic
mRNA was isolated from total RNA by immunomagnetic beads (Dy-period of HIV infection is a strong predictor of fast pro-
nal) specific for poly(A) sequences. Purified mRNA was then tran-gression to AIDS (Gandhi and Walker, 2002; Mellors et
scribed into cDNA using Moloney murine leukemia virus reverse
al., 1995, 1996). Thus, a practical intervention that could transcriptase (Invitrogen). A 632 base pair-long F-MuLV env frag-
reduce virus loads during chronic HIV infection would ment was amplified from the cDNA with the same PCR protocol
described above. Control samples subjected to PCR amplificationlikely be an invaluable tool in postponing the onset of
without prior reverse transcription did not yield PCR signals indicat-AIDS. While it remains to be seen whether an interven-
ing that there was no contamination by proviral DNA. In some experi-tion such as described in this paper would work in HIV
ments the amplified fragments were directly sequenced to verifyinfections, our experiments open up new possibilities of
the F-MuLV env specificity of the PCR products. Uninfected mice
therapy for treating chronicity, one of the most refractory were always negative by RNA and DNA PCR.
elements of retroviral infections.
Sequencing of the FV GagL T Cell Epitope
Total RNA and DNA were extracted with Trizol (Invitrogen) fromExperimental Procedures
spleen cell suspensions of mice persistently infected with FV. mRNA
was isolated from total RNA and reverse transcribed into cDNA asMice
Experiments were done with (C57BL/10 x A.BY)F1 mice (H-2b/b, Fv1b, described above. Proviral DNA and the cDNA were then used to
amplify a 481 base pair-long fragment of the F-MuLV gag gene,Fv2r/s), C57BL/6, the two B6 congenic strains B6.PL (Thy 1.1 con-
genic), and B6.SJL (CD45.1 congenics) as noted in the figure leg- including the gag leader sequence. The primers were: sense primer,
5-CGGCCAGAGTCCAACCATCC-3; antisense primer, 3-TCCCAGends. The DbGagL TCR Tg (T cell receptor transgenic) mice were
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GTCACGATGTAGGGG-5. The fragment from each sample was di- 70 	g of antibody was injected i.p. every other day beginning on
the day of adoptive transfer. The mice were injected a total of sixrectly sequenced to determine the FV GagL epitope sequence and
its flanking sequences at the 3 and 5 ends. The primer used for times. Control mice were treated by i.p. injection of nonspecific rat
immunoglobulin (Sigma, St. Louis, MO) on the same schedule assequencing was the antisense primer mentioned above. The nucleo-
tide sequence was determined with a Prism 3100 (Applied Biosys- the experimental groups. Mice were depleted of CD25 T cells by
i.p. injection of 1 mg of purified anti-CD25 monoclonal antibodytems) automated sequencer.
(Suvas et al., 2003) from clone PC61.5.3 from Accurate Chemical
and Scientific Corp. (Westbury, NY). Adoptive transfers were doneInfectious-Center Assays
on day 3 following depletion when 0.2% or fewer CD25 cells re-Serial dilutions of spleen cells from infected mice were plated onto
mained in the peripheral blood. IL-10 receptor was blocked in vivo bysusceptible Mus dunni cells, cocultivated for 3 days, fixed with
i.p. injection of anti-IL-10R (mAb IB1.3a, a gift from Robert Coffman,ethanol, stained with F-MuLV envelope-specific MAb720, and devel-
DNAX, Palo Alto, CA) as previously described (Dittmer et al., 2002).oped with peroxidase-conjugated goat anti-mouse IgG and sub-
In the anti-IL-10R experiment there were no significant differencesstrate to detect foci of infected cells (Dittmer et al., 1998).
between untreated mice and persistently infected mice that received
anti-IL-10R, anti-IL-10R with 4  106 CD8 T cells, or only 4  106Tetramers and Tetramer Staining
CD8 T cells.For detection of Db-GagL-specific CD8 T cells, nucleated spleen
cells were dually stained with APC-labeled anti-CD8 (Ly-2) (BD Phar-
Acknowledgmentsmingen) and PE-labeled MHC class I H2-Db tetramers specific for
FV GagL peptide (Db-GagL tetramers) for 15 min at room tempera-
This work was supported by the NIAID intramural research programture. The Db-GagL tetramers were constructed by the NIAID tetramer
and by a grant to U.D. from the Deutsche Forschungsgemeinschaftfacility using a peptide in which all three cysteine residues were
(Di 714/6-1/2).replaced with amino-butyric acid to prevent interpeptide disulfide
bonding as has been described (Schepers et al., 2002). This variant
peptide is recognized by polyclonal GagL-specific CD8 T cells as Received: September 20, 2003
determined by intracellular interferon- staining. Cells were washed Revised: January 7, 2004
two times, resuspended in buffer with propidium iodide, and ana- Accepted: January 27, 2004
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